Large Target Markets
Large Target Markets
AMR is creating a global need for new antibacterials.
In 2014, WHO predicted that by 2050 antibiotic resistance would kill more people than cancer. The WHO GLASS survey (2021), which noted few novel drugs in the pipeline to address the declining effectiveness of antibiotics, effectively confirmed the 2014 prediction.
Antimicrobial resistance is creating a global need for new antibacterials.
The US$20+ billion need for novel solutions will only increase as antibiotic resistance increases and few new drugs come to market. In the US, the cost of AMR is up to $55 billion per year ($20B in healthcare services, $35B in lost productivity). AMR is the largest growing unmet medical need in the world: the WHO estimates an annual cost of $1 trillion and 10 million deaths per year by 2050.
In addition, there are multiple product applications for other under-met medical needs – such as:
■ Pneumonia ($19.7B market) ■ Bed Sores ($6.0B market)
■ Eczema ($6.5+B market) ■ Burn Infections ($2.7B market)
■ Acne ($6.0B market) ■ Periprosthetic Joint Infections ($1.8B market; fast growing)
